A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
This is a Phase I Dose Escalation Study in which the safety, tolerability and efficacy of
Amphinex®--induced Photochemical Internalisation (PCI) of Gemcitabine followed by
Gemcitabine/Cisplatin Chemotherapy will be assessed in patients with advanced inoperable
cholangiocarcinomas.